The Enterprise Value as of June 2026 (TTM) for Denali Therapeutics Inc. (DNLI) is 3.09B

According to Denali Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.09B. This represents a change of 15.25% compared to the average of 2.68B of the last 4 quarters.

Denali Therapeutics Inc. (DNLI) Historical Enterprise Value (quarterly & annually)

How has DNLI Enterprise Value performed in the past?

The mean historical Enterprise Value of Denali Therapeutics Inc. over the last ten years is 2.96B. The current 3.09B Enterprise Value has changed 10.32% with respect to the historical average. Over the past ten years (40 quarters), DNLI's Enterprise Value was at its highest in in the December 2020 quarter at 9.63B. The Enterprise Value was at its lowest in in the June 2016 quarter at 0.

Denali Therapeutics Inc. (DNLI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Denali Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Denali Therapeutics Inc. (DNLI) Average Enterprise Value

How has DNLI Enterprise Value performed in the past?

The current Enterprise Value of Denali Therapeutics Inc. (DNLI) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Denali Therapeutics Inc. (DNLI) Enterprise Value vs. Peers

How is DNLI’s Enterprise Value compared to its peers?

Denali Therapeutics Inc.’s Enterprise Value is greater than Arcus Biosciences, Inc. (2.31B), greater than Agios Pharmaceuticals, Inc. (1.67B), greater than 89bio, Inc. (2.11B), less than ImmunityBio, Inc. (8.36B), greater than Beam Therapeutics Inc. (2.95B), greater than Recursion Pharmaceuticals, Inc. (826.56M), less than Cogent Biosciences, Inc. (5.65B), greater than Galapagos N.V. (1.58B), less than Liquidia Corporation (6.30B), greater than Viridian Therapeutics, Inc. (1.35B),

Build a custom stock screener for Denali Therapeutics Inc. (DNLI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Denali Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Denali Therapeutics Inc. (DNLI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Denali Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.